NBP

0.83005.66%
SG

Srishti Gupta

CEO & Director

Dr. Srishti Gupta, M.D., MPP, is CEO & Director of NovaBridge Biosciences from July 1, 2026. She was CEO & Executive Director of Idorsia Ltd from July 1, 2025 to March 2026. She served as Independent Director of Invivyd, Inc. since May 21, 2024 until May 2025. She has been Director at Santhera Pharmaceuticals Holding AG since May 26, 2026. She was a Non-Executive Director at Idorsia Ltd since May 12, 2021 until July 1, 2025. Dr. Gupta Professional background: Global Director, Alumni Strategy and Engagement at McKinsey & Company, 2020-present. Director of Global Development Programs at McKinsey & Company, 2016-2020. Regional Manager, Diversity & Inclusion at McKinsey & Company, 2014-2016. Senior Expert for the McKinsey Global Health Practice at McKinsey & Company, 2003-2014. She is an experienced physician leader with experience in health and a global career spanning various sectors, including private, public and non-profit. Dr. Gupta's Other activities and functions: Member of the Harvard University Global Advisory Council. Vice-Chair on the Board of the International School of Basel. Dr. Gupta completed her M.D. at Harvard Medical School and M.P.P focusing on international development at Harvard Kennedy School of Government. In addition, she holds a Doctor of Medicine from Harvard Medical School; a Master of Public Policy in international development from Harvard Kennedy School; a Master of Philosophy in Natural Sciences from the University of Cambridge; and a Master of Arts in Molecular and Cellular Biology and a Bachelor of Arts in Biological Sciences, both from Harvard University.

Positions